Retroviral gene therapy: safety issues and possible solutions.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Current Gene Therapy

• Publication date

  2005-01-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/1566523052997514PMID 15638709
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ex Vivo Gene Therapy for Skeletal Regeneration in Cranial Defects Compromised by Postoperative Radiotherapy

  2003cited by this paper
• Seeking the Cause of Induced Leukemias in X-SCID Trial

  2003cited by this paper
• Side effects of retroviral gene transfer into hematopoietic stem cells.

  2003cited by this paper
• Elimination of Leukemia in the Absence of Lethal Graft-Versus-Host Disease After Allogenic Bone Marrow Transplantation

  2003cited by this paper
• Scaffold attachment region-containing retrovirus vectors improve long-term proviral expression after transplantation of GFP-modified CD34+ baboon repopulating cells.

  2003cited by this paper
• A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency.

  2003cited by this paper
• Identification of anti-repressor elements that confer high and stable protein production in mammalian cells

  2003cited by this paper
• Drug discovery with engineered zinc-finger proteins

  2003cited by this paper
• The Choice of a Suitable Lentivirus Vector

  2003cited by this paper
• Occurrence of leukaemia following gene therapy of X-linked SCID

  2003cited by this paper
• Gene therapy of thyroid cancer via retrovirally-driven combined expression of human interleukin-2 and herpes simplex virus thymidine kinase.

  2003cited by this paper
• Human immunodeficiency virus type 1-based vectors for gene delivery to human hematopoietic stem cells.

  2003cited by this paper
• Occurrence of leukaemia following gene therapy of X-linked SCID

  2003cited by this paper
• Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration

  2003cited by this paper
• Gene therapy's new era: a balance of unequivocal benefit and unequivocal harm.

  2003cited by this paper
• Directed evolution of retroviruses activatable by tumour-associated matrix metalloproteases

  2003cited by this paper
• Long-term replacement of a mutated nonfunctional CNS gene: reversal of hypothalamic diabetes insipidus using an EIAV-based lentiviral vector expressing arginine vasopressin.

  2003cited by this paper
• Progress and problems with the use of viral vectors for gene therapy

  2003cited by this paper
• Hepatoma cell-specific ganciclovir-mediated toxicity of a lentivirally transduced HSV-TkEGFP fusion protein gene placed under the control of rat alpha-fetoprotein gene regulatory sequences

  2003cited by this paper
• Gene therapy for arthritis.

  2003cited by this paper
• Clinical-Scale Selection of Anti-CD3/CD28–Activated T Cells After Transduction with a Retroviral Vector Expressing Herpes Simplex Virus Thymidine Kinase and Truncated Nerve Growth Factor Receptor

  2002cited by this paper
• Specific transduction of HIV-1 envelope expressing cells by retroviral vectors pseudotyped with hybrid CD4/CXCR4 receptors.

  2002cited by this paper
• Lentiviruses in gene therapy clinical research

  2002cited by this paper
• HIV-1 integration in the human genome favors active genes and local hotspots.

  2002cited by this paper
• Retroviral gene therapy vectors for prevention of excimer laser-induced corneal haze.

  2002cited by this paper
• Retrovirus-Mediated Herpes Simplex Virus Thymidine Kinase Gene Transfer in Pancreatic Cancer Cell Lines: An Incomplete Antitumor Effect

  2002cited by this paper
• Setting the boundaries of chromatin domains and nuclear organization.

  2002cited by this paper
• Development of gene-based therapies for cartilage repair.

  2002cited by this paper
• Gene transfer approaches to the healing of bone and cartilage.

  2002cited by this paper
• The insulation of genes from external enhancers and silencing chromatin

  2002cited by this paper
• The murine whey acidic protein promoter directs expression to human mammary tumors after retroviral transduction

  2002cited by this paper
• Envelope-targeted retrovirus vectors transduce melanoma xenografts but not spleen or liver.

  2002cited by this paper
• Topological constraints governing the use of the chicken HS4 chromatin insulator in oncoretrovirus vectors.

  2002cited by this paper
• Development of virus vectors for gene therapy of beta chain hemoglobinopathies: flanking with a chromatin insulator reduces gamma-globin gene silencing in vivo.

  2002cited by this paper
• Muscle-Based Gene Therapy and Tissue Engineering for Treatment of Growth Plate Injuries

  2002cited by this paper
• Regeneration of hyaline cartilage by cell-mediated gene therapy using transforming growth factor beta 1-producing fibroblasts.

  2001cited by this paper
• Receptors and Entry Cofactors for Retroviruses Include Single and Multiple Transmembrane-Spanning Proteins as well as Newly Described Glycophosphatidylinositol-Anchored and Secreted Proteins

  2001cited by this paper
• Efficient in vitro and in vivo gene regulation of a retrovirally delivered pro-apoptotic factor under the control of the Drosophila HSP70 promoter

  2001cited by this paper
• Improved post-transcriptional processing of an MDR1 retrovirus elevates expression of multidrug resistance in primary human hematopoietic cells

  2001cited by this paper
• Bone-directed expression of Col1a1 promoter-driven self-inactivating retroviral vector in bone marrow cells and transgenic mice.

  2001cited by this paper
• Specifically targeted killing of carcinoembryonic antigen (CEA)-expressing cells by a retroviral vector displaying single-chain variable fragmented antibody to CEA and carrying the gene for inducible nitric oxide synthase.

  2001cited by this paper
• Silencing of gene expression: implications for design of retrovirus vectors

  2001cited by this paper
• The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs.

  2001cited by this paper
• Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.

  2001cited by this paper
• Use of Intron-Disrupted Polyadenylation Sites To Enhance Expression and Safety of Retroviral Vectors

  2001cited by this paper
• Directed evolution of a recombinase for improved genomic integration at a native human sequence.

  2001cited by this paper
• Gene therapy for hepatocellular carcinoma based on tumour-selective suicide gene expression using the alpha-fetoprotein (AFP) enhancer and a housekeeping gene promoter.

  2001cited by this paper
• A New-Generation Stable Inducible Packaging Cell Line for Lentiviral Vectors

  2001cited by this paper
• Development of an Rev-Independent, Minimal Simian Immunodeficiency Virus-Derived Vector System

  2001cited by this paper
• Regeneration of Hyaline Cartilage by Cell-Mediated Gene Therapy Using Transforming Growth Factor β1-Producing Fibroblasts

  2001cited by this paper
• Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors.

  2001cited by this paper
• The sea urchin sns insulator blocks CMV enhancer following integration in human cells.

  2001cited by this paper
• Receptor-Specific Targeting Mediated by the Coexpression of a Targeted Murine Leukemia Virus Envelope Protein and a Binding-Defective Influenza Hemagglutinin Protein

  2001cited by this paper
• Enzyme engineering: rational redesign versus directed evolution.

  2001cited by this paper
• mdr1 promoter-driven tumor necrosis factor-α expression for a chemotherapy-controllable combined in vivo gene therapy and chemotherapy of tumors

  2000cited by this paper
• Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.

  2000cited by this paper
• High efficiency retroviral vectors that contain no viral coding sequences

  2000cited by this paper
• A chromatin insulator protects retrovirus vectors from chromosomal position effects.

  2000cited by this paper
• Targeting retrovirus to cancer cells expressing a mutant EGF receptor by insertion of a single chain antibody variable domain in the envelope glycoprotein receptor binding lobe.

  2000cited by this paper
• Transcriptional augmentation: modulation of gene expression by scaffold/matrix-attached regions (S/MAR elements).

  2000cited by this paper
• Gene therapy: trials and tribulations

  2000cited by this paper
• Targeting Human T Cells by Retroviral Vectors Displaying Antibody Domains Selected from a Phage Display Library

  2000cited by this paper
• Inhibition of metastatic tumor growth in nude mice by portal vein infusions of matrix-targeted retroviral vectors bearing a cytocidal cyclin G1 construct.

  2000cited by this paper
• The Best of Times, the Worst of Times

  2000cited by this paper
• Clinical trials in the gene therapy of arthritis.

  2000cited by this paper
• Increasing endothelial cell specific expression by the use of heterologous hypoxic and cytokine-inducible enhancers

  2000cited by this paper
• Molecular Engineering of Matrix-Targeted Retroviral Vectors Incorporating a Surveillance Function Inherent in von Willebrand Factor

  2000cited by this paper
• Generation of a high titre retroviral vector for endothelial cell-specific gene expression in vivo

  2000cited by this paper
• Retroviral Vector Targeting to Human Immunodeficiency Virus Type 1-Infected Cells by Receptor Pseudotyping

  2000cited by this paper
• Split-Intron Retroviral Vectors: Enhanced Expression with Improved Safety

  2000cited by this paper
• The cHS4 Insulator Increases the Probability of Retroviral Expression at Random Chromosomal Integration Sites

  2000cited by this paper
• Orthopaedic gene therapy.

  2000cited by this paper
• Gibbon Ape Leukemia Virus Receptor Functions of Type III Phosphate Transporters from CHOK1 Cells Are Disrupted by Two Distinct Mechanisms

  1999cited by this paper
• Efficient gene delivery to quiescent interleukin-2 (IL-2)-dependent cells by murine leukemia virus-derived vectors harboring IL-2 chimeric envelope glycoproteins.

  1999cited by this paper
• Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectors

  1999cited by this paper
• Persistent Zoonotic Infection of a Human with Simian Foamy Virus in the Absence of an Intact orf-2Accessory Gene

  1999cited by this paper
• Phase I trial of interferon-γ (IFN-γ) retroviral vector administered intratumorally to patients with metastatic melanoma

  1999cited by this paper
• Phase I trial of interferon-gamma (IFN-gamma) retroviral vector administered intratumorally to patients with metastatic melanoma.

  1999cited by this paper
• A highly efficient method for the site-specific integration of transfected plasmids into the genome of mammalian cells using purified retroviral integrase.

  1998cited by this paper
• Setting the Boundaries?

  1998cited by this paper
• Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery

  1998cited by this paper
• Simian Sarcoma-Associated Virus Fails To Infect Chinese Hamster Cells despite the Presence of Functional Gibbon Ape Leukemia Virus Receptors

  1998cited by this paper
• Getting a handhold on DNA: design of poly-zinc finger proteins with femtomolar dissociation constants.

  1998cited by this paper
• The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis.

  1998cited by this paper
• In vivo selection of protease cleavage sites from retrovirus display libraries

  1998cited by this paper
• Identification of a human population infected with simian foamy viruses

  1998cited by this paper
• Human Matrix Attachment Regions Insulate Transgene Expression from Chromosomal Position Effects in Drosophila melanogaster

  1998cited by this paper
• Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors

  1998cited by this paper
• Inverse targeting of retroviral vectors: selective gene transfer in a mixed population of hematopoietic and nonhematopoietic cells.

  1998cited by this paper
• Gene therapy for arthritis

  1998cited by this paper
• Scaffold Attachment Region-Mediated Enhancement of Retroviral Vector Expression in Primary T Cells

  1998cited by this paper
• A large nucleoprotein assembly at the ends of the viral DNA mediates retroviral DNA integration

  1997cited by this paper
• HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia.

  1997cited by this paper
• Tethering human immunodeficiency virus type 1 preintegration complexes to target DNA promotes integration at nearby sites

  1997cited by this paper
• Characterization of the chicken beta-globin insulator.

  1997cited by this paper
• Simian foamy virus isolated from an accidentally infected human individual

  1997cited by this paper
• Employment of the mdr1 promoter for the chemotherapy-inducible expression of therapeutic genes in cancer gene therapy

  1997cited by this paper
• A Gene Delivery System Activatable by Disease-Associated Matrix Metalloproteinases

  1997cited by this paper
• Targeting of retroviral vectors through protease-substrate interactions.

  1996cited by this paper
• Targeting of retroviral integrase by fusion to a heterologous DNA binding domain: in vitro activities and incorporation of a fusion protein into viral particles.

  1996cited by this paper

• The design of retroviral vectors used in the CAR‐T products, risk management, and future perspective

  2025cites this paper
• Gene Therapy in Diabetic Retinopathy and Diabetic Macular Edema: An Update

  2025cites this paper
• Gene therapy in neovascular age related macular degeneration: an update

  2025cites this paper
• Significance of gene therapy in neurodegenerative diseases

  2025cites this paper
• Nucleic acid-based drugs for patients with solid tumours

  2024cites this paper
• STAT5 activation enhances adoptive therapy combined with peptide vaccination by preventing PD-1 inhibition.

  2024cites this paper
• A cellular disease model toward gene therapy of TGM1-dependent lamellar ichthyosis

  2024cites this paper
• Multifunctional nanoplatforms application in the transcatheter chemoembolization against hepatocellular carcinoma

  2023cites this paper
• The recombinase activating genes: architects of immune diversity during lymphocyte development

  2023cites this paper
• Recent advances in gene therapy: genetic bullets to the root of the problem

  2022cites this paper
• Nonviral Expression of LL-37 in a Human Skin Equivalent to Prevent Infection in Skin Wounds

  2021cites this paper
• Understanding In Vivo Fate of Nucleic Acid and Gene Medicines for the Rational Design of Drugs

  2021cites this paper
• Engineering Human Skin Equivalents to Prevent Infections in Skin Wounds

  2021cites this paper
• Viral vector‐based gene therapies in the clinic

  2021cites this paper
• RNA-electroporated T cells for cancer immunotherapy

  2020cites this paper
• NOX2ko Mice Show Largely Increased Expression of a Mutated NOX2 mRNA Encoding an Inactive NOX2 Protein

  2020cites this paper
• Clinical development on the frontier: gene therapy for duchenne muscular dystrophy

  2020cites this paper
• Characterization of polydactyly chondrocytes and their use in cartilage engineering

  2019cites this paper
• Emerging areas of bone repair materials

  2019cites this paper
• Multi-functional self-assembled nanoparticles for pVEGF-shRNA loading and anti-tumor targeted therapy.

  2019cites this paper
• Safety evaluation of conditionally immortalized cells for renal replacement therapy

  2019cites this paper
• Gene Therapy in Pathologic Scars

  2018cites this paper
• Molecular Analyses Support the Safety and Activity of Retroviral Replicating Vector Toca 511 in Patients

  2018cites this paper
• Gene Therapy in Reconstructive and Regenerative Surgery

  2018cites this paper
• Chapter 16 Retroviral Genotoxicity

  2017cites this paper
• Controlled Gene Delivery Systems for Articular Cartilage Repair

  2017cites this paper
• An Ecological Framework of the Human Virome Provides Classification of Current Knowledge and Identifies Areas of Forthcoming Discovery

  2016cites this paper
• Long-Term Safety Follow-Up of Subjects Previously Treated with Non-Replicating Retroviral Vector-Based Gene Therapies

  2016cites this paper
• Targeting the ubiquitin proteasome system to develop novel therapeutic approaches for spinal muscular atrophy

  2016influential citation
• The role of miRNAs in stroke

  2015cites this paper
• The therapeutic potential of genome editing for β-thalassemia

  2015cites this paper
• Targeted delivery of anti-cancer drugs by MS2 virus-like particles

  2015cites this paper
• Fluorescence microscopy colocalization of lipid-nucleic acid nanoparticles with wildtype and mutant Rab5-GFP: A platform for investigating early endosomal events.

  2015cites this paper
• Hydroxyapatite nanoparticles modified by branched polyethylenimine are effective non-viral vectors for siRNA transfection of hepatoma cells in vitro.

  2015cites this paper
• Cell mediated gene therapy: A guide for doctors in the clinic

  2015cites this paper
• Gene Therapy of Malignant Glioma Hanna Stedt Gene Therapy of Malignant Glioma Alternative Strategies and Combination Therapies

  2015cites this paper
• Adoptive immunotherapy for treatment of chronic hepatitis B

  2014cites this paper
• The relevance of biomaterials to the prevention and treatment of osteoporosis.

  2014cites this paper
• A preliminary step of a novel strategy in suicide gene therapy with lentiviral vector

  2014cites this paper
• Poly(amino ether) based Polymeric and Nanoparticle Systems for Nucleic Acid Delivery and Bioimaging

  2014cites this paper
• Cyclodextrin/Dendrimer conjugates as DNA and oligonucleotide carriers.

  2014cites this paper
• Reprogramming peripheral blood mononuclear cells using an efficient feeder-free, non-integration method to generate iPS cells and the effect of immunophenotype and epigenetic state on HSPC fate

  2014influential citation
• Oncogene dependency and the potential of targeted RNAi-based anti-cancer therapy.

  2014cites this paper
• Fibril formation by naturally occurring prostatic acid phosphatase fragments and their effect on viral infection and transduction

  2014cites this paper
• Molecular targets to treat muscular dystrophies.

  2014cites this paper
• Uptake and transfection efficiency of PEGylated cationic liposome-DNA complexes with and without RGD-tagging.

  2014cites this paper
• Characterization of Genetically Modified HUCPVCs as an Osteogenic Cell Source.

  2014cites this paper
• Vacunas de ADN Plasmídico: Una Herramienta Terapéutica Emergente

  2014cites this paper
• Neue Behandlungsansätze bei erblich bedingten Myopathien

  2013cites this paper
• Viral vectors: a look back and ahead on gene transfer technology.

  2013cites this paper
• Gene therapy : what it is , what it is not and what it will be

  2013cites this paper
• Gene-Directed Enzyme Prodrug Cancer Therapy

  2013cites this paper
• Retroviral Genotoxicity

  2013cites this paper
• Poly(aminoether)-gold nanorod assemblies for shRNA plasmid-induced gene silencing.

  2013cites this paper
• Construction of Expression Vector for Anti-Alpha-Fetoprotein Gene and Its Inhibition Effects on Alpha-Fetoprotein Positive Hepg 2 Cells

  2012cites this paper
• Construction of Expression Vector for Anti-Alpha-Fetoprotein Gene and Its Inhibition Effects on Alpha-Fetoprotein Positive Hepg2 Cells

  2012cites this paper
• Use of RNA interference to minimize ischemia reperfusion injury.

  2012cites this paper
• The Sleeping Beauty transposon system for clinical applications

  2012cites this paper
• Antitumoural hydroxyapatite nanoparticles‐mediated hepatoma‐targeted trans‐arterial embolization gene therapy: in vitro and in vivo studies

  2012cites this paper
• Advances in Ultrasound Mediated Gene Therapy Using Microbubble Contrast Agents

  2012cites this paper
• Novel possible pharmaceutical research tools: stem cells, gene delivery and their combination.

  2012cites this paper
• TIMP-2 Fusion Protein with Human Serum Albumin Potentiates Anti-Angiogenesis-Mediated Inhibition of Tumor Growth by Suppressing MMP-2 Expression

  2012cites this paper
• Transgene delivery using poly(amino ether)‐gold nanorod assemblies

  2012cites this paper
• Gene therapy: implications for craniofacial regeneration.

  2012cites this paper
• Modeling of gene therapy for regenerative cells using intelligent agents.

  2011cites this paper
• The Glucocorticoid Receptor in Retroviral Infection

  2011cites this paper
• Current Advances in Retroviral Gene Therapy

  2011cites this paper
• Ultrasound-assisted non-viral gene transfer to the salivary glands

  2011cites this paper
• Meniskus Tissue Engineering

  2011cites this paper
• Retroviral Integration Target Site Selection

  2011cites this paper
• Biomedical Applications of Single-Walled Carbon Nanotubes

  2011cites this paper
• Computational and Theoretical Concepts for Regulating Stem Cells Using Viral and Physical Methods

  2010cites this paper
• Plasmid Purification, Therapeutic Applications

  2010cites this paper
• In vivo bioluminescence imaging for monitoring of siRNA mediated luciferase knockdown in tumor models

  2010cites this paper
• RNA Interference: The Next Gene‐Targeted Medicine

  2010cites this paper
• The role of transglutaminase 2 and osteopontin in matrix protein supplemented microencapsulation of marrow stromal cells.

  2010cites this paper
• Ultrasound-assisted non-viral gene transfer to the salivary glands

  2010cites this paper
• Transactivation of the dopamine receptor 3 gene by a single provirus integration results in development of B-cell lymphoma in transgenic mice generated from retrovirally transduced embryonic stem cells.

  2010cites this paper
• Terapia gênica: o que é, o que não é e o que será

  2010cites this paper
• Gene therapy: Have the risks associated with viral vectors been solved?

  2010cites this paper
• The influence of mediators of intracellular trafficking on transgene expression efficacy of polymer-plasmid DNA complexes.

  2010cites this paper
• siRNA: Sojourn from discovery to delivery challenges and clinics

  2010cites this paper
• The possible use of stem cells in regenerative medicine: dream or reality?

  2009cites this paper
• Therapeutic opportunities of small interfering RNA

  2009cites this paper
• Not gene therapy, but genetic surgery—the right strategy to attack cancer

  2009cites this paper
• The Role of Insulators in Genome Organization and Gene Expression

  2009cites this paper
• Cloning and characterization of MRI, a modulator of retroviral infection

  2009cites this paper
• Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR.

  2009cites this paper
• Parallel synthesis and screening of polymers for nonviral gene delivery.

  2009cites this paper
• The development of gene therapy: from monogenic recessive disorders to complex diseases such as cancer.

  2009cites this paper
• Current developments in anti-HIV/AIDS gene therapy.

  2009cites this paper
• Recent Findings Concerning PAMAM Dendrimer Conjugates with Cyclodextrins as Carriers of DNA and RNA

  2009cites this paper
• Gene therapy and bone marrow stem-cell transfer to treat autoimmune disease.

  2009cites this paper
• In Vivo Cellular Imaging for Translational Medical Research.

  2009cites this paper
• Lentiviral vector-mediated SERCA2 gene transfer protects against heart failure and left ventricular remodeling after myocardial infarction in rats.

  2008cites this paper
• Coupling erythropoietin secretion to mesenchymal stromal cells enhances their regenerative properties.

  2008cites this paper
• Erythropoietic porphyrias: animal models and update in gene-based therapies.

  2008cites this paper
• Improving safety of gene therapy.

  2008cites this paper
• Cholesteryl cytofectins with primary amino head groups transfect transformed human epithelial cell lines efficiently.

  2008cites this paper
• Lentiviruses inefficiently incorporate human parainfluenza type 3 envelope proteins

  2008cites this paper